Paxman AB (publ) (PAX.ST) Stock Analysis & Winston Score

Paxman AB is a Swedish medical device company that makes scalp cooling systems used during chemotherapy. Its main product is a cap that patients wear on their head during cancer treatment — the cold temperature reduces blood flow to the scalp, which helps prevent hair loss. The company sells primarily to hospitals and cancer treatment centers around the world. Paxman earns revenue by selling or leasing its cooling hardware to healthcare facilities and charging for the single-use caps that patients wear during each treatment session. The company operates globally, with a strong presence in Europe and a growing footprint in the United States, which is its most important growth market. With a near-zero operating margin and slightly negative ROIC, the business is not yet consistently profitable, and its key challenge is scaling US adoption fast enough to cover its operating costs while competing against rival scalp cooling systems from companies like Dignitana.